Cargando…

Corrigendum: Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Holst, Frederik, Hoivik, Erling A., Gibson, William J., Taylor-Weiner, Amaro, Schumacher, Steven E., Asmann, Yan W., Grossmann, Patrick, Trovik, Jone, Necela, Brian M., Thompson, E. Aubrey, Meyerson, Matthew, Beroukhim, Rameen, Salvesen, Helga B., Cherniack, Andrew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Corrigenda
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492263/ https://www.ncbi.nlm.nih.gov/pubmed/28664899 http://dx.doi.org/10.1038/srep46873

Ejemplares similares

Corrigendum: Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth
por: Holst, Frederik, et al.
Publicado: (2016)

Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth
por: Holst, Frederik, et al.
Publicado: (2016)

Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients
por: Berg, Anna, et al.
Publicado: (2014)

The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis
por: Gibson, William J., et al.
Publicado: (2016)

Corrigendum: SIKs control osteocyte responses to parathyroid hormone
por: Wein, Marc N., et al.
Publicado: (2017)

Corrigendum: A fluorescent hormone biosensor reveals the dynamics of jasmonate signalling in plants
por: Larrieu, Antoine, et al.
Publicado: (2016)

Corrigendum: Migraine and possible etiologic heterogeneity for hormone-receptor-negative breast cancer
por: Shi, Min, et al.
Publicado: (2016)

Corrigendum: Exposure to Sound Vibrations Lead to Transcriptomic, Proteomic and Hormonal Changes in Arabidopsis
por: Ghosh, Ritesh, et al.
Publicado: (2016)

High visceral fat percentage is associated with poor outcome in endometrial cancer
por: Mauland, Karen Klepsland, et al.
Publicado: (2017)

Hormonal Modulation of ESR1 Mutant Metastasis
por: Gu, Guowei, et al.
Publicado: (2020)

Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients
por: Mauland, Karen Klepsland, et al.
Publicado: (2017)

Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene
por: Hoivik, Erling A., et al.
Publicado: (2014)

High-Throughput Mutation Profiling of Primary and Metastatic Endometrial Cancers Identifies KRAS, FGFR2 and PIK3CA to Be Frequently Mutated
por: Krakstad, Camilla, et al.
Publicado: (2012)

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer
por: Hortobagyi, G N, et al.
Publicado: (2019)

Corrigendum to “Zand L, Canetta P, Lafayette R, et al. An open-label pilot study of adrenocorticotrophic hormone in the treatment of IgA nephropathy at high risk of progression.” Kidney Int Rep. 2020;5:58–65
Publicado: (2020)

PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer
por: Mjos, Siv, et al.
Publicado: (2017)

An MRI-Based Radiomic Prognostic Index Predicts Poor Outcome and Specific Genetic Alterations in Endometrial Cancer
por: Jacob, Havjin, et al.
Publicado: (2021)

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
por: Mermel, Craig H, et al.
Publicado: (2011)

Integrated Genomic Analysis of the 8q24 Amplification in Endometrial Cancers Identifies ATAD2 as Essential to MYC-Dependent Cancers
por: Raeder, Maria B., et al.
Publicado: (2013)

Corrigendum: Novel concept for neutron detection: proportional counter filled with (10)B nanoparticle aerosol
por: Amaro, F. D., et al.
Publicado: (2018)

Differential Expression of MicroRNAs in Tumors from Chronically Inflamed or Genetic (APC(Min/+)) Models of Colon Cancer
por: Necela, Brian M., et al.
Publicado: (2011)

Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer
por: Kusonmano, Kanthida, et al.
Publicado: (2018)

Corrigendum: Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC
por: Aerts, Hugo J. W. L., et al.
Publicado: (2017)

ESR1 ligand binding domain mutations in hormone-resistant breast cancer
por: Toy, Weiyi, et al.
Publicado: (2013)

ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma
por: Krakstad, Camilla, et al.
Publicado: (2015)

Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival
por: Mauland, Karen Klepsland, et al.
Publicado: (2016)

Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer
por: Reinert, Tomas, et al.
Publicado: (2017)

Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer
por: Berg, Anna, et al.
Publicado: (2016)

Corrigendum: Human Mitochondrial DNA-Protein Complexes Attach to a Cholesterol-Rich Membrane Structure
por: Gerhold, Joachim M., et al.
Publicado: (2015)

Endometrial cancer cells exhibit high expression of p110β and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation
por: Karlsson, Thomas, et al.
Publicado: (2016)

Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers
por: Berg, Anna, et al.
Publicado: (2017)

Antiemetic treatment of hyperemesis gravidarum in 1,064 Norwegian women and the impact of European warning on metoclopramide: a retrospective cohort study 2002–2019
por: Erdal, Hilde, et al.
Publicado: (2022)

Corrigendum: Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
por: Aerts, Hugo J.W.L., et al.
Publicado: (2014)

Analytical protocol to identify local ancestry-associated molecular features in cancer
por: Carrot-Zhang, Jian, et al.
Publicado: (2021)

HER2 expression patterns in paired primary and metastatic endometrial cancer lesions
por: Halle, Mari Kyllesø, et al.
Publicado: (2018)

ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer
por: Brett, Jamie O., et al.
Publicado: (2021)

The influence of ESR1 polymorphisms on selected hormonal, metabolic and mineral balance markers in women with hyperandrogenism
por: Uzar, Izabela, et al.
Publicado: (2022)

Blood Metabolites Associate with Prognosis in Endometrial Cancer
por: Strand, Elin, et al.
Publicado: (2019)

Incretin hormones and the satiation signal
por: Holst, J J
Publicado: (2013)

Corrigendum: Worldwide variations in artificial skyglow
por: Kyba, Christopher C. M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ti97anmmf2fhkfupihri0msvbj